LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

UNH

327.41

+1.82%↑

NVS

130.21

+2.49%↑

ABT

126.93

+0.93%↑

Search

Stryker Corp

Abierto

SectorSalud

363.69 2.57

Resumen

Variación precio

24h

Actual

Mínimo

353.71

Máximo

363.61

Métricas clave

By Trading Economics

Ingresos

-25M

859M

Ventas

35M

6.1B

P/B

Media del Sector

47.188

77.256

BPA

3.19

Rentabilidad por dividendo

0.94

Margen de beneficio

14.182

Empleados

53,000

EBITDA

-108M

1.4B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+20.94% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.94%

2.33%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-9.7B

137B

Apertura anterior

361.12

Cierre anterior

363.69

Noticias sobre sentimiento de mercado

By Acuity

23%

77%

57 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Stryker Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

30 oct 2025, 20:36 UTC

Ganancias

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31 jul 2025, 20:42 UTC

Ganancias

Stryker Lifts Guidance on Improving Tariff Outlook

1 may 2025, 20:56 UTC

Ganancias

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

5 nov 2025, 19:38 UTC

Ganancias

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Ganancias

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 oct 2025, 20:21 UTC

Ganancias

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Adj EPS $3.19 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q EPS $2.22 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Sales $6.1B >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Net $859M >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Adj EPS $3.19 >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Net $859M >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q Sales $6.06B >SYK

30 oct 2025, 20:05 UTC

Ganancias

Stryker 3Q EPS $2.22 >SYK

31 jul 2025, 20:09 UTC

Ganancias

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31 jul 2025, 20:09 UTC

Ganancias

Stryker Sales >SYK

31 jul 2025, 20:09 UTC

Ganancias

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Sales $6B >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Net $884M >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q EPS $2.29 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Adj EPS $3.13 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q Sales $6B >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q EPS $2.29 >SYK

31 jul 2025, 20:05 UTC

Ganancias

Stryker 2Q EPS $2.29 >SYK

1 may 2025, 20:41 UTC

Ganancias

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1 may 2025, 20:11 UTC

Ganancias

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1 may 2025, 20:10 UTC

Ganancias

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1 may 2025, 20:05 UTC

Ganancias

Stryker 1Q Adj EPS $2.84 >SYK

Comparación entre iguales

Cambio de precio

Stryker Corp Esperado

Precio Objetivo

By TipRanks

20.94% repunte

Estimación a 12 meses

Media 430.6 USD  20.94%

Máximo 455 USD

Mínimo 392 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Stryker Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

15 ratings

12

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

373.92 / 383.99Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

57 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat